Previously dba Cryomedical Sciences, Inc and Cell Preservation Services Inc., BioLife Solutions is organized around offering a proprietary, clinical-grade biopreservation media for cells and tissues: low-temperature technologies for use in preserving and prolonging the viability of cellular and genetic material for use in cell therapy and tissue engineering. The firm's HypoThermosol® hypothermic storage and CryoStor® cryopreservation freeze media are employed in the regenerative medicine, biobanking and drug discovery markets. These novel biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death; offering commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function.
